The role of apparent diffusion coefficient in the grading of adult isocitrate dehydrogenase-mutant astrocytomas: relationship with the Ki-67 proliferation index

Abstract

Background

The grading of adult isocitrate dehydrogenase (IDH)-mutant astrocytomas is a crucial prognostic factor.

Purpose

To investigate the value of conventional magnetic resonance imaging (MRI) features and apparent diffusion coefficient (ADC) in the grading of adult IDH-mutant astrocytomas, and to analyze the correlation between ADC and the Ki-67 proliferation index.

Material and Methods

The clinical and MRI data of 82 patients with adult IDH-mutant astrocytoma who underwent surgical resection and molecular genetic testing with IDH and 1p/19q were retrospectively analyzed. The conventional MRI features, ADC_min, ADC_mean, and nADC of the tumors were compared using the Kruskal–Wallis single factor ANOVA and chi-square tests. Receiver operating characteristic (ROC) curves were drawn to evaluate conventional MRI and ADC accuracy in differentiating tumor grades. Pearson correlation analysis was performed to determine the correlation between ADC and the Ki-67 proliferation index.

Results

The difference in enhancement, ADC_min, ADC_mean, and nADC among WHO grade 2, 3, and 4 tumors was statistically significant (all P <0.05). ADC_min showed the preferable diagnostic accuracy for grading WHO grade 2 and 3 tumors (AUC=0.724, sensitivity=63.4%, specificity=80%, positive predictive value (PPV)=62.0%; negative predictive value (NPV)=82.5%), and distinguishing grade 3 from grade 4 tumors (AUC=0.764, sensitivity=70%, specificity=76.2%, PPV=75.0%, NPV=71.4%). Enhancement + ADC model showed an optimal predictive accuracy (grade 2 vs. 3: AUC = 0.759; grade 3 vs. 4: AUC = 0.799). The Ki-67 proliferation index was negatively correlated with ADC_min, ADC_mean, and nADC (all P <0.05), and positively correlated with tumor grade.

Conclusion

Conventional MRI features and ADC are valuable to predict pathological grading of adult IDH-mutant astrocytomas.

Keywords

Apparent diffusion coefficient astrocytomas isocitrate dehydrogenase-mutant Ki-67 proliferation index

Get full access to this article

View all access options for this article.

References

Louis

Perry

Wesseling

, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 2021;23:1231–1251.

Whitfield

Huse

. Classification of adult-type diffuse gliomas: impact of the World Health Organization 2021 update. Brain Pathol 2022;32:e13062.

Yang

Xing

, et al. Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI. Eur Radiol 2023;33:7003–7014.

Jakola

Skjulsvik

Myrmel

, et al. Surgical resection versus watchful waiting in low-grade gliomas. Ann Oncol 2017;28:1942–1948.

Wang

Yan

, et al. Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study. Neurosurg Rev 2021;44:1447–1455.

Weller

van den Bent

Preusser

, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 2021;18:170–186.

Low

Ostrom

Cioffi

, et al. Primary brain and other central nervous system tumors in the United States (2014–2018): a summary of the CBTRUS statistical report for clinicians. Neurooncol Pract 2022;9:165–182.

Xiaoai

Qing

Lei

Junlin

. Differentiating microcystic meningioma from atypical meningioma using diffusion-weighted imaging. Neuroradiology 2020;62:601–607.

Meyer

Wienke

Surov

. ADC values of benign and high grade meningiomas and associations with tumor cellularity and proliferation-A systematic review and meta-analysis. J Neurol Sci 2020;415:116975.

10.

Dury

Lourdusamy

Macarthur

, et al. Meta-analysis of apparent diffusion coefficient in pediatric medulloblastoma, ependymoma, and pilocytic astrocytoma. J Magn Reson Imaging 2022;56:147–157.

11.

Yang

Xing

She

, et al. Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging. BMC Med Imaging 2022;22:105.

12.

Joyner

Garrett

Batchala

, et al. MRI features predict tumor grade in isocitrate dehydrogenase (IDH)-mutant astrocytoma and oligodendroglioma. Neuroradiology 2023;65:121–129.

13.

Liu

Wang

Wei

, et al. Role of diffusion-weighted imaging in differentiating angiomatous meningioma from atypical meningioma. Clin Neurol Neurosurg 2022:107406.

14.

Gerdes

Schwab

Lemke

, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13–20.

15.

Yuan

Zeng

Liu

, et al. DWI and IVIM are predictors of Ki67 proliferation index: direct comparison of MRI images and pathological slices in a murine model of rhabdomyosarcoma. Eur Radiol 2020;30:1334–1341.

16.

Zeng

Zhou

Wen

, et al. The relationship between the expression of Ki-67 and the prognosis of osteosarcoma. BMC Cancer 2021;21:210.

17.

Duregon

Bertero

Pittaro

, et al. Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas. Oncotarget 2016;7:21190–21198.

18.

Shaffrey

Farace

Schiff

, et al. The Ki-67 labeling index as a prognostic factor in Grade II oligoastrocytomas. J Neurosurg 2005;102:1033–1039.

19.

Pouget

Hergalant

Lardenois

, et al. Ki-67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1-mutant and 1p/19q-codeleted: a multicenter study from the French POLA network. Brain Pathol 2020;30:465–478.

20.

Qin

Zhang

Wang

, et al. Combination value of diffusion-weighted imaging and dynamic susceptibility contrast-enhanced MRI in astrocytoma grading and correlation with GFAP, Topoisomerase IIα and MGMT. Oncol Lett 2019;18:2763–2770.

21.

Franceschi

Tosoni

Bartolini

, et al. Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas. Eur J Cancer 2020;137:10–17.

22.

Zhao

Liu

, et al. Apparent diffusion coefficient values effectively predict cell proliferation and determine oligodendroglioma grade. Neurosurg Rev 2023;46:83.

23.

Zhang

Chen

, et al. Grading and proliferation assessment of diffuse astrocytic tumors with monoexponential, biexponential, and stretched-exponential diffusion-weighted imaging and diffusion kurtosis imaging. Eur J Radiol 2018;109:188–195.

24.

Bai

Lin

Tian

, et al. Grading of gliomas by using monoexponential, biexponential, and stretched exponential diffusion-weighted MR imaging and diffusion kurtosis MR imaging. Radiology 2016;278:496–504.

25.

Jiang

Zhang

, et al. Application of neurite orientation dispersion and density imaging in assessing glioma grades and cellular proliferation. World Neurosurg 2019;131:e247–e254.

26.

Xie

Zhang

Liu

, et al. Minimal apparent diffusion coefficient in predicting the Ki-67 proliferation index of pancreatic neuroendocrine tumors. Jpn J Radiol 2022;40:823–830.

27.

Han

Zhang

Liu

, et al. Differentiating atypical meningioma from anaplastic meningioma using diffusion weighted imaging. Clin Imaging 2022;82:237–243.

28.

Huang

Zhu

, et al. Native T1-mapping and diffusion-weighted imaging (DWI) can be used to identify lung cancer pathological types and their correlation with Ki-67 expression. J Thorac Dis 2022;14:443–454.

29.

Feraco

Bacci

Ferrazza

, et al. Magnetic resonance imaging derived biomarkers of IDH mutation status and overall survival in grade III astrocytomas. Diagnostics (Basel) 2020;10:247.

30.

Ostrom

Shoaf

Cioffi

, et al. National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States. Neuro Oncol 2023;25:799–807.

31.

Karschnia

Young

Dono

, et al. Prognostic validation of a new classification system for extent of resection in glioblastoma: a report of the ANO resect group. Neuro Oncol 2023;25:940–954.